Estrogen memory effect in human hepatocytes during repeated cell division without hormone.

Transient stimulation of target tissues by sex steroids can cause long-lasting changes that may facilitate or alter responses to subsequent hormonal treatment. How these altered characteristics are propagated during cell division in the absence of the stimulating hormone is unknown. The human hepatocarcinoma cell line HepG2 was used as a model to examine the effects of estrogen on the synthesis of serum apolipoproteins in vitro. Treatment with low concentrations of estrogen for 24 to 48 hours resulted in long-lasting alterations in the kinetics with which the cells responded to subsequent stimulation with estrogen. Manifestation of this memory effect was correlated quantitatively with the induction and propagation of a moderate-affinity, nuclear, estrogen-binding protein with the characteristics of a type II estrogen receptor. The data indicate that transient exposure of these cells to estrogen can induce changes in their response characteristics and composition of nuclear proteins that are inherited by daughter cells grown in the absence of hormone for more than ten generations.

[1]  T. Archer,et al.  Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells: mechanism of antagonism by testosterone. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Archer,et al.  Kinetics of estrogen-dependent modulation of apolipoprotein A-I synthesis in human hepatoma cells. , 1986, The Journal of biological chemistry.

[3]  J. H. Clark,et al.  Uterine type II estrogen-binding sites are not of eosinophil origin. , 1986, Journal of Biological Chemistry.

[4]  H. Weintraub.  Assembly and propagation of repressed and derepressed chromosomal states , 1985, Cell.

[5]  K. Kok,et al.  Nuclease-hypersensitive sites in chromatin of the estrogen-inducible apoVLDL II gene of chicken. , 1985, Nucleic acids research.

[6]  T. Archer,et al.  Effects of estrogen on apolipoprotein secretion by the human hepatocarcinoma cell line, HepG2. , 1985, The Journal of biological chemistry.

[7]  T. Archer,et al.  Apolipoprotein C-II mRNA levels in primate liver. Induction by estrogen in the human hepatocarcinoma cell line, HepG2. , 1985, The Journal of biological chemistry.

[8]  H. Weintraub,et al.  Temporal order of chromatin structural changes associated with activation of the major chicken vitellogenin gene , 1983, Cell.

[9]  M. Gruber,et al.  Methylation of the chicken vitellogenin gene: influence of estradiol administration. , 1983, Nucleic acids research.

[10]  J. H. Clark,et al.  Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites. , 1982, Cancer research.

[11]  J. H. Clark,et al.  Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange. , 1981, Endocrinology.

[12]  P. Searle,et al.  Vitellogenin gene expression in male xenopus hepatocytes during primary and secondary stimulation with estrogen in cell cultures , 1981, Cell.

[13]  C C Howe,et al.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. , 1980, Science.

[14]  A. Jeffrey,et al.  How the λ repressor and cro work , 1980, Cell.

[15]  J. Jost,et al.  Appearance of vitellogenin mRNA sequences and rate of vitellogenin synthesis in chicken liver following primary and secondary stimulation by 17 beta-estradiol. , 1978, European journal of biochemistry.

[16]  D. J. Shapiro,et al.  Kinetics of estrogen induction of Xenopus laevis vitellogenin messenger RNA as measured by hybridization to complementary DNA. , 1977, The Journal of biological chemistry.

[17]  J. Gordon,et al.  Kinetics of avian vitellogenin messenger RNA induction. Comparison between primary and secondary response to estrogen. , 1977, The Journal of biological chemistry.